Cargando…

Association of Plasma Transforming Growth Factor-β1 Levels and the Risk of Atrial Fibrillation: A Meta-Analysis

INTRODUCTION: Numerous studies have demonstrated that plasma transforming growth factor-β1 (TGF-β1) may be involved in the pathogenesis of atrial fibrillation (AF), but some discrepancy remained. We performed a meta-analysis to evaluate the association between the plasma level of TGF-β1 and the risk...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Jiao, Yang, Yajuan, Ng, Chee Yuan, Zhang, Zhiwei, Liu, Tong, Li, Guangping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4865111/ https://www.ncbi.nlm.nih.gov/pubmed/27171383 http://dx.doi.org/10.1371/journal.pone.0155275

Ejemplares similares

Thiazolidinedione use and atrial fibrillation in diabetic patients: a meta-analysis
por: Zhang, Zhiwei, et al.
Publicado: (2017)

Association of Cancer and the Risk of Developing Atrial Fibrillation: A Systematic Review and Meta-Analysis
por: Yuan, Ming, et al.
Publicado: (2019)

Serum glycated hemoglobin level as a predictor of atrial fibrillation: A systematic review with meta-analysis and meta-regression
por: Qi, Wenwei, et al.
Publicado: (2017)

Association between transforming growth factor β1 polymorphisms and atrial fibrillation in essential hypertensive subjects
por: Wang, Yongzheng, et al.
Publicado: (2010)

Inhibition of renin-angiotensin axis reduces the risk of thrombus formation in the left atrial appendage in patients with hypertension complicated by atrial fibrillation
por: Suo, Ya, et al.
Publicado: (2018)

Serum level of transforming growth factor beta 1 is associated with left atrial voltage in patients with chronic atrial fibrillation
por: Zhao, Shilu, et al.
Publicado: (2017)

Elevated plasma Ninjurin-1 levels in atrial fibrillation is associated with atrial remodeling and thromboembolic risk
por: Fang, Chen, et al.
Publicado: (2022)

The Therapeutic Potential of MicroRNAs in Atrial Fibrillation
por: Xu, Xiaona, et al.
Publicado: (2020)

Biomarkers for Predicting Left Atrial or Left Atrial Appendage Thrombus in Anticoagulated Patients with Nonvalvular Atrial Fibrillation
por: Zhou, Xue, et al.
Publicado: (2020)

Circulating Galectin-3 and Atrial Fibrillation Recurrence after Catheter Ablation: A Meta-Analysis
por: Zhang, Guangping, et al.
Publicado: (2019)

Plasma growth differentiation factor‐15 in patients with “lone” atrial fibrillation
por: Li, Na, et al.
Publicado: (2022)

Reactive oxygen species mediated oxidative stress links diabetes and atrial fibrillation
por: Liang, Xue, et al.
Publicado: (2018)

Galectin‐3 and risk of atrial fibrillation: A systematic review and meta‐analysis
por: Gong, Mengqi, et al.
Publicado: (2020)

Higher Incidence of Atrial Fibrillation in Left Ventricular-to-Right Atrial Shunt Patients
por: Chou, Hongda, et al.
Publicado: (2020)

Efficacy of Wenxin Keli Plus Amiodarone versus Amiodarone Monotherapy in Treating Recent-Onset Atrial Fibrillation
por: Zhang, Nixiao, et al.
Publicado: (2018)

Irbesartan prevents sodium channel remodeling in a canine model of atrial fibrillation
por: Wang, Xuewen, et al.
Publicado: (2018)

The Expression Levels of Plasma micoRNAs in Atrial Fibrillation Patients
por: Liu, Zheng, et al.
Publicado: (2012)

Serum Beta-2 Microglobulin: A Possible Biomarker for Atrial Fibrillation
por: Zhang, Bangying, et al.
Publicado: (2021)

Elevated Levels of Plasma Transforming Growth Factor‐β in Patients with Hepatocellular Carcinoma
por: Shirai, Yasuhiro, et al.
Publicado: (1992)

Decreased plasma musclin levels are associated with potential atrial fibrillation in non-diabetic patients
por: Zhong, Yuan, et al.
Publicado: (2021)

Elevated plasma levels of Th17-related cytokines are associated with increased risk of atrial fibrillation
por: Wu, Na, et al.
Publicado: (2016)

Catheter Ablation of Atrial Fibrillation Raises the Plasma Level of NGF-β Which Is Associated with Sympathetic Nerve Activity
por: Park, Jae Hyung, et al.
Publicado: (2015)

Steroids prevent early recurrence of atrial fibrillation following catheter ablation: a systematic review and meta-analysis
por: Lei, Ming, et al.
Publicado: (2018)

Sacubitril/Valsartan Improves Left Atrial and Left Atrial Appendage Function in Patients With Atrial Fibrillation and in Pressure Overload-Induced Mice
por: Suo, Ya, et al.
Publicado: (2019)

Plasma endothelin-1 levels are increased in atrial fibrillation patients with hyperthyroidism
por: Mayyas, Fadia, et al.
Publicado: (2018)

Interleukin-22 is elevated in the atrium and plasma of patients with atrial fibrillation and increases collagen synthesis in transforming growth factor-β1-treated cardiac fibroblasts via the JNK pathway
por: Wu, Yongxin, et al.
Publicado: (2020)

High uric acid level predicts left atrial thrombus or spontaneous echo contrast detected by transesophageal echocardiography: Meta-analysis and systematic review
por: Zhang, En-Yuan, et al.
Publicado: (2016)

Suppression of amyloid-β fibril growth by drug-engineered polymorph transformation
por: Mafimoghaddam, Sima, et al.
Publicado: (2022)

Bone Morphogenetic Protein-7 Antagonizes Myocardial Fibrosis Induced by Atrial Fibrillation by Restraining Transforming Growth Factor-β (TGF-β)/Smads Signaling
por: Chen, Xinjun, et al.
Publicado: (2016)

Notching early repolarization pattern in inferior leads increases risk of ventricular tachyarrhythmias in patients with acute myocardial infarction: a meta-analysis
por: Zhang, Zhiwei, et al.
Publicado: (2015)

Manganese Superoxide Dismutase as a Novel Oxidative Stress Biomarker for Predicting Paroxysmal Atrial Fibrillation
por: Liu, Hao, et al.
Publicado: (2022)

Association of Hemostatic Markers with Atrial Fibrillation: A Meta-Analysis and Meta-Regression
por: Wu, Na, et al.
Publicado: (2015)

Alogliptin, a Dipeptidyl Peptidase‐4 Inhibitor, Alleviates Atrial Remodeling and Improves Mitochondrial Function and Biogenesis in Diabetic Rabbits
por: Zhang, Xiaowei, et al.
Publicado: (2017)

Comparison of Circumferential Pulmonary Vein Isolation and Antiarrhythmic Drug Therapy in Patients with Atrial Fibrillation
por: Xu, Yanmin, et al.
Publicado: (2012)

Association between Sleep Apnea Hypopnea Syndrome and the Risk of Atrial Fibrillation: A Meta-Analysis of Cohort Study
por: Zhao, Enfa, et al.
Publicado: (2018)

Doxycycline Improves Fibrosis-Induced Abnormalities in Atrial Conduction and Vulnerability to Atrial Fibrillation in Chronic Intermittent Hypoxia Rats
por: Ma, Zuowang, et al.
Publicado: (2020)

Clinical Implications of Unmasking Dormant Conduction After Circumferential Pulmonary Vein Isolation in Atrial Fibrillation Using Adenosine: A Systematic Review and Meta-Analysis
por: Chen, Cheng, et al.
Publicado: (2019)

Plasma Total Homocysteine Level Is Related to Unfavorable Outcomes in Ischemic Stroke With Atrial Fibrillation
por: Nam, Ki‐Woong, et al.
Publicado: (2022)

Relaxin-2 plasma levels in atrial fibrillation are linked to inflammation and oxidative stress markers
por: Aragón-Herrera, Alana, et al.
Publicado: (2022)

Circulating Vitamin D Concentrations and Risk of Atrial Fibrillation: A Mendelian Randomization Study Using Non-deficient Range Summary Statistics
por: Zhang, Nan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_2gngq8an67c20n6inb5m2tic1h